Cargando…
Nitroxoline inhibits bladder cancer progression by reversing EMT process and enhancing anti-tumor immunity
Nitroxoline is considered to be an effective treatment for the urinary tract infections. Recently, it has been found to be effective against several cancers. However, few studies have examined the anti-tumor activity of nitroxoline in bladder cancer. The purpose of the study was to reveal the possib...
Autores principales: | Xu, Naijin, Lin, Wenfeng, Sun, Jingkai, Sadahira, Takuya, Xu, Abai, Watanabe, Masami, Guo, Kai, Araki, Motoo, Li, Gonghui, Liu, Chunxiao, Nasu, Yasutomo, Huang, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545671/ https://www.ncbi.nlm.nih.gov/pubmed/33046984 http://dx.doi.org/10.7150/jca.47025 |
Ejemplares similares
-
Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer
por: Lin, Wenfeng, et al.
Publicado: (2021) -
The Novel Combination of Nitroxoline and PD-1 Blockade, Exerts a Potent Antitumor Effect in a Mouse Model of Prostate Cancer
por: Xu, Naijin, et al.
Publicado: (2019) -
Dual-Functional PLGA Nanoparticles Co-Loaded with Indocyanine Green and Resiquimod for Prostate Cancer Treatment
por: Lin, Wenfeng, et al.
Publicado: (2021) -
Synergistic effects of the immune checkpoint inhibitor CTLA-4 combined with the growth inhibitor lycorine in a mouse model of renal cell carcinoma
por: Li, Xiezhao, et al.
Publicado: (2017) -
Identification of MICALL2 as a Novel Prognostic Biomarker Correlating with Inflammation and T Cell Exhaustion of Kidney Renal Clear Cell Carcinoma
por: Lin, Wenfeng, et al.
Publicado: (2022)